Suwon, South Korea

Kang Ro Lee

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kang Ro Lee. Retrieved from https://idiyas.com/inventor/kang-ro-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Kang Ro Lee in Anti-Cancer Research.

Introduction

Kang Ro Lee is an innovative inventor based in Suwon, South Korea. He has made significant contributions to the field of anti-cancer research through his patented inventions. His work focuses on developing effective treatments that can combat tumor growth and cancer progression.

Latest Patents

Kang Ro Lee holds a patent for "Thymol derivatives having anti-tumor activity, and anti-cancer agent comprising the same." This invention relates to a thymol derivative represented by a specific chemical formula, along with its pharmaceutically acceptable salts or esters. The active ingredient in this patent serves as a promising anti-cancer agent.

Career Highlights

Throughout his career, Kang Ro Lee has demonstrated a commitment to advancing medical science. His research has the potential to provide new avenues for cancer treatment, showcasing his dedication to improving patient outcomes.

Collaborations

Kang Ro Lee has worked alongside notable colleagues, including Ok Pyo Zee and Young Hoon Jung. Their collaborative efforts contribute to the innovative research environment that fosters groundbreaking discoveries.

Conclusion

Kang Ro Lee's contributions to anti-cancer research through his patented inventions highlight his role as a significant figure in the field. His work continues to inspire advancements in cancer treatment and showcases the importance of innovation in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…